Organisation paid for research Program year 2025 Source: CMS Open Payments

Wetlin Research Associates

Neither a doctor nor a teaching hospital

Research payments

$127,969

521 payments

Through program year 2025, Wetlin Research Associates is reported as receiving $127,969 in research payments, across 521 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $22,155 11
2024 Research $76,589 307
2023 Research $23,332 202
2019 Research $5,893 1

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $122,076 520 payments
  2. AstraZeneca Pharmaceuticals LP $5,893 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Nn9535-4801 $122,076 520 payments
  2. Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) $5,893 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record